ADUS stock icon

Addus HomeCare
ADUS

$126.37
2.48%

Market Cap: $2.29B

 

About: Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.

Employees: 34,846

0
Funds holding %
of 6,686 funds
0
Analysts bullish %
of 8 analysts

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

105% more call options, than puts

Call options by funds: $2.79M | Put options by funds: $1.36M

88% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 25

23% more capital invested

Capital invested by funds: $1.65B [Q1] → $2.03B (+$375M) [Q2]

8% more funds holding

Funds holding: 261 [Q1] → 283 (+22) [Q2]

8.16% more ownership

Funds ownership: 98.76% [Q1] → 106.93% (+8.16%) [Q2]

9% more repeat investments, than reductions

Existing positions increased: 104 | Existing positions reduced: 95

0% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]

Research analyst outlook

8 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$128
1%
upside
Avg. target
$138
9%
upside
High target
$143
13%
upside

8 analyst ratings

positive
100%
neutral
0%
negative
0%
RBC Capital
Ben Hendrix
80% 1-year accuracy
47 / 59 met price target
12%upside
$141
Outperform
Reiterated
3 Sept 2024
RBC Capital
Ben Hendrix
80% 1-year accuracy
47 / 59 met price target
12%upside
$141
Outperform
Maintained
8 Aug 2024
TD Cowen
Ryan Langston
100% 1-year accuracy
5 / 5 met price target
8%upside
$137
Buy
Maintained
8 Aug 2024
Stephens & Co.
Scott Fidel
90% 1-year accuracy
28 / 31 met price target
13%upside
$143
Overweight
Maintained
7 Aug 2024
Oppenheimer
Michael Wiederhorn
76% 1-year accuracy
25 / 33 met price target
11%upside
$140
Outperform
Maintained
7 Aug 2024

Financial journalist opinion